Open AccessDirect and Indirect Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Use on Invasive Pneumococcal Disease (IPD) Among Children and Adults
Author(s) -
Tamara Pilishvili,
Ryan Gierke,
Monica M. Farley,
William Schaffner,
Ann Thomas,
Arthur Reingold,
Lee H. Harrison,
Ruth Lynfield,
Shelley M. Zansky,
Susan Petit,
Lisa A. Miller,
Joseph Bareta,
Bernard Beall,
Matthew R. Moore,
Cynthia G. Whitney
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw194.79
Subject(s) - pneumococcal disease , medicine , pneumococcal conjugate vaccine , streptococcus pneumoniae , pneumococcal infections , pediatrics , immunology , microbiology and biotechnology , antibiotics , biology
Tamara Pilishvili, Centers for Disease Control and Prevention Ryan Gierke, Centers for Disease Control and Prevention Monica Farley, Emory University William Schaffner, Emory University Ann Thomas, Oregon Public Health Division Arthur Reingold, University of California Lee Harrison, University of Pittsburgh Ruth Lynfield, Minnesota Department of Health Shelley M. Zansky, New York State Department of Health Susan Petit, Connecticut Emerging Infections Program
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom